Evommune, Inc.
Clinical trials sponsored by Evommune, Inc., explained in plain language.
-
New eczema drug shows promise in clinical trial
Disease control Recruiting nowThis study is testing whether an experimental medication called EVO756 can help control moderate to severe eczema in adults. Researchers are comparing different doses of EVO756 against a placebo in 120 participants to see which works best and is safest. The study measures how muc…
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for people with uncontrollable hives
Disease control Recruiting nowThis study is testing a new drug called EVO756 to see if it can reduce the severity of chronic hives in adults. It will compare several doses of the drug against a placebo in 160 people whose hives are not well-controlled by standard allergy pills. The main goal is to see how muc…
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC